Transcatheter valve repair and replacement.
There is significant interest in developing transcatheter therapy for valvular heart disease (VHD). Numerous devices have been developed for the percutaneous treatment of pulmonary and aortic stenosis as well as mitral regurgitation. Several of these devices have progressed to randomized clinical trials. These ongoing trials for aortic stenosis and mitral regurgitation will provide important insights into the durability of these therapies as well as the results following standard surgical repair. The field of transcatheter valve therapy is rapidly evolving, and this review aims to summarize the current status of the field.
Kodali
Susheel
S
Columbia University Medical Center, New York, New York 10032, USA. sk2427@columbia.edu
Schwartz
Allan
A
D001024:Aortic Valve Stenosis / Q000601:surgery*; D006328:Cardiac Catheterization; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000601:surgery*; D011474:Prosthesis Design